Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05378178
Recruitment Status : Recruiting
First Posted : May 18, 2022
Last Update Posted : July 7, 2022
Information provided by (Responsible Party):
Jiangsu Hansoh Pharmaceutical Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2023
Estimated Study Completion Date : December 31, 2024